The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations

Xieraili Wumener,Yarong Zhang,Zihan Zang,Fen Du,Xiaoxing Ye,Maoqun Zhang,Ming Liu,Jiuhui Zhao,Tao Sun,Ying Liang
DOI: https://doi.org/10.1186/s12890-024-02997-9
IF: 3.1
2024-05-12
BMC Pulmonary Medicine
Abstract:18 F-fluorodeoxyglucose (FDG) PET/CT has been widely used for the differential diagnosis of cancer. Semi-quantitative standardized uptake value (SUV) is known to be affected by multiple factors and may make it difficult to differentiate between benign and malignant lesions. It is crucial to find reliable quantitative metabolic parameters to further support the diagnosis. This study aims to evaluate the value of the quantitative metabolic parameters derived from dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting epidermal growth factor receptor (EGFR) mutation status.
respiratory system
What problem does this paper attempt to address?